Skip to main content
construction release_alert
Profile editing is temporarily unavailable from June 11-24, 2026 while manual profile data entry transitions to Elements. Learn More.
cancel
Journal cover image

Prophylactic amiodarone versus lidocaine for prevention of reperfusion ventricular fibrillation after release of aortic cross-clamp.

Publication ,  Journal Article
Ayoub, CM; Sfeir, PM; Bou-Khalil, P; Azar, M; Haddadin, AS; Harfouch, D; Nasr, VG; El-Khatib, MF
Published in: Eur J Anaesthesiol
December 2009

BACKGROUND AND OBJECTIVE: Ventricular fibrillation is common after aortic cross-clamp release in patients undergoing open-heart surgeries. The aim of the study was to evaluate the efficacy of the prophylactic administration of 150 mg amiodarone by way of the pump 2 min before release of aortic cross-clamp in preventing ventricular fibrillation. METHODS: The present study is a prospective, randomized, controlled and blinded study performed at a teaching university hospital where 120 patients undergoing coronary bypass graft surgery were randomly assigned to three groups. Each group received either 150 mg of amiodarone or 100 mg lidocaine or isotonic saline by way of pump 2 min before release of the aortic cross-clamp. The frequency of occurrence of ventricular fibrillation and the subsequent required defibrillation counter shocks were determined in all groups. RESULTS: The frequency of occurrence of ventricular fibrillation was significantly higher in both the amiodarone (48%) and the control group (45%) as compared with the lidocaine group (20%) with no statistically significant difference between the amiodarone and the control groups. Furthermore, when ventricular fibrillation occurred, the percentage of patients requiring defibrillation counter shocks was significantly higher in both the amiodarone (58%) and control (61%) groups as compared with the lidocaine group (13%) with no difference between the amiodarone and the control groups, despite a significant decrease in the defibrillation counter shocks energy requirements in the amiodarone group. CONCLUSION: The present study showed no difference between amiodarone (150 mg) and placebo in preventing ventricular fibrillation after release of aortic cross-clamp. In addition, the use of lidocaine was able to reduce the incidence of ventricular fibrillation as compared with both amiodarone and placebo.

Duke Scholars

Published In

Eur J Anaesthesiol

DOI

EISSN

1365-2346

Publication Date

December 2009

Volume

26

Issue

12

Start / End Page

1056 / 1060

Location

England

Related Subject Headings

  • Ventricular Fibrillation
  • Treatment Outcome
  • Myocardial Reperfusion
  • Middle Aged
  • Male
  • Lidocaine
  • Humans
  • Female
  • Coronary Artery Bypass
  • Clinical Protocols
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ayoub, C. M., Sfeir, P. M., Bou-Khalil, P., Azar, M., Haddadin, A. S., Harfouch, D., … El-Khatib, M. F. (2009). Prophylactic amiodarone versus lidocaine for prevention of reperfusion ventricular fibrillation after release of aortic cross-clamp. Eur J Anaesthesiol, 26(12), 1056–1060. https://doi.org/10.1097/EJA.0b013e32832f0dfb
Ayoub, Chakib M., Pierre M. Sfeir, Pierre Bou-Khalil, Mireille Azar, Ala’ S. Haddadin, Diala Harfouch, Viviane G. Nasr, and Mohamad F. El-Khatib. “Prophylactic amiodarone versus lidocaine for prevention of reperfusion ventricular fibrillation after release of aortic cross-clamp.Eur J Anaesthesiol 26, no. 12 (December 2009): 1056–60. https://doi.org/10.1097/EJA.0b013e32832f0dfb.
Ayoub CM, Sfeir PM, Bou-Khalil P, Azar M, Haddadin AS, Harfouch D, et al. Prophylactic amiodarone versus lidocaine for prevention of reperfusion ventricular fibrillation after release of aortic cross-clamp. Eur J Anaesthesiol. 2009 Dec;26(12):1056–60.
Ayoub, Chakib M., et al. “Prophylactic amiodarone versus lidocaine for prevention of reperfusion ventricular fibrillation after release of aortic cross-clamp.Eur J Anaesthesiol, vol. 26, no. 12, Dec. 2009, pp. 1056–60. Pubmed, doi:10.1097/EJA.0b013e32832f0dfb.
Ayoub CM, Sfeir PM, Bou-Khalil P, Azar M, Haddadin AS, Harfouch D, Nasr VG, El-Khatib MF. Prophylactic amiodarone versus lidocaine for prevention of reperfusion ventricular fibrillation after release of aortic cross-clamp. Eur J Anaesthesiol. 2009 Dec;26(12):1056–1060.
Journal cover image

Published In

Eur J Anaesthesiol

DOI

EISSN

1365-2346

Publication Date

December 2009

Volume

26

Issue

12

Start / End Page

1056 / 1060

Location

England

Related Subject Headings

  • Ventricular Fibrillation
  • Treatment Outcome
  • Myocardial Reperfusion
  • Middle Aged
  • Male
  • Lidocaine
  • Humans
  • Female
  • Coronary Artery Bypass
  • Clinical Protocols